Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis
Alison E. John(Imperial College London), Robert J. Slack(GlaxoSmithKline (United Kingdom))
Cited by 123
Related Papers
Defining the mechanism of galectin-3–mediated TGF-β1 activation and its role in lung fibrosis
|Journal of Biological Chemistry|2024|30
The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis
|Respiratory Research|2023|17
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1